Novo Nordisk Restructures to Focus on Obesity and Diabetes Treatments
Novo Nordisk, a leading pharmaceutical company, is making big changes to focus more on obesity and diabetes treatments. Their CEO […]
Pharmaceutical News
Pharmaceutical News
New In-Line System Improves Tablet Quality Checks in Drug Manufacturing
A new monitoring system has been developed to enhance quality testing during the production of pharmaceutical tablets. This innovation could
Merck & Co Cancels Major UK Research Plans and Cuts Jobs
Merck & Co (also known as MSD outside the US) has decided to cancel its plans for a £1 billion
Pharmaceutical News
US Biotech LB Pharmaceuticals Breaks 2025 IPO Drought with Strong Funding
US-based biotech company LB Pharmaceuticals has successfully raised significant funds through an initial public offering (IPO), breaking a dry spell
New Study Shows Long-Term Benefits of Eptinezumab for Chronic Migraine Patients
Lundbeck, a pharmaceutical company, shared new research about eptinezumab at the 2025 International Headache Congress in São Paulo. The data
Pharmaceutical News
New System Helps Check Tablet Quality During Manufacturing
A team of researchers in Japan has developed a new way to check the quality of medicine tablets as they
New FDA-Approved Autoinjector for Alzheimer’s Treatment Offers Convenient Option
Eisai and Biogen have received FDA approval for LEQEMBI IQLIK (lecanemab-irmb), a new autoinjector for maintaining treatment in early Alzheimer’s
Biotech Investor Otello Stampacchia on Industry Challenges and Future Outlook
Otello Stampacchia, a seasoned biotech investor, has seen the industry face many tough times over the past 20 years. He
New Startup Braveheart Bio Licenses Chinese Heart Drug for Global Development
A new pharmaceutical startup called Braveheart Bio has just acquired the rights to a promising heart medication originally developed in
FDA Reconsiders Rare Disease Drug, Setting Precedent for Future Treatments
A debate between Stealth BioTherapeutics and the FDA over a drug for Barth syndrome—a rare, often fatal childhood disease—could set